Clinical Trial Update: BMAC in Severe Hip or Knee Osteoarthritis Awaiting Arthroplasty [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial of bone-marrow-derived autologous cell therapy (BMAC) in severe hip or knee osteoarthritis awaiting arthroplasty was withdrawn after Phase 2/Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip
• Osteoarthritis of the Knee

Drugs mentioned

• BMAC (bone-marrow–derived autologous cell therapy)

Snippet

Sponsor: CAPRI Clinic | Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip | Phase 2, Phase 3 | Status: WITHDRAWN